New asthma drug shows promise for controlling symptoms and cough

NCT ID NCT05922891

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 35 times

Summary

This study tested how well tezepelumab works for adults with severe asthma that is not controlled by other treatments. It focused on improving asthma control and reducing cough. 92 participants were followed for a year to see real-world effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site

Aomori, Japan
Research Site

Bunkyō City, Japan
Research Site

Fujisawa, Japan
Research Site

Fukuoka, Japan
Research Site

Fukushima, Japan
Research Site

Hamamatsu, Japan
Research Site

Hiroshima, Japan
Research Site

Iizuka, Japan
Research Site

Izumo, Japan
Research Site

Kawasaki, Japan
Research Site

Kitakyushu, Japan
Research Site

Kiyose, Japan
Research Site

Kurashiki, Japan
Research Site

Matsusaka, Japan
Research Site

Minami, Japan
Research Site

Minato, Japan
Research Site

Nagoya, Japan
Research Site

Naka, Japan
Research Site

Niigata, Japan
Research Site

Nishinomiya, Japan
Research Site

Osaka, Japan
Research Site

Sapporo, Japan
Research Site

Shinagawa City, Japan
Research Site

Shinjuku, Japan
Research Site

Shizuoka, Japan
Research Site

tabashi City, Japan
Research Site

Tennōjichō-kita, Japan
Research Site

Ube, Japan
Research Site

Yonago, Japan

Conditions

Explore the condition pages connected to this study.

ASTHMA